Author: Agarwal Piyush K Black Peter C McConkey David J Dinney Colin PN
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.12, Iss.3, 2007-09, pp. : 435-448
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. :
Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy
Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. :
Emerging Immunotargets in Bladder Cancer
Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. :
Cancer-Targeted Polymeric Drugs
Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-09 ,pp. :
Emerging drugs for colorectal cancer
By Fogelman David R Kopetz Scott Eng Cathy
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. :